On June 13, 2024, Mindray and Inpeco have officially signed a strategic cooperation agreement at Mindray's headquarters in Shenzhen, China, marking a new era of innovation and collaboration in the in vitro diagnostics industry. This collaboration is founded on the companies’ mutual excellence in their respective fields, as well as their shared values and vision for the future.
Mindray, a global leader in medical devices and solutions, is committed to enhancing healthcare services through cutting-edge innovation. Inpeco, known for its pioneering and avant-garde laboratory automation solutions, has made a significant global impact with its advanced technology and superior product quality. This strategic cooperation unites the strengths of both companies to drive further advancements in healthcare.
Through this collaboration, Mindray's hematology solution will be integrated with Inpeco's Total Laboratory Automation (TLA) systems. Moving forward, the integration of data management with other IVD products in biochemistry and immunology will consistently exceed global customer expectations for automation. Through resource sharing and technological collaboration, we aim to enhance the overall quality of products and services, delivering greater value to customers worldwide.
Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to deliver secure test results and increased efficiency to clinical laboratories around the world. To date, more than 2600 Inpeco systems have been shipped to over 78 countries. Inpeco also provides automation for Anatomical Pathology and is developing solutions for Blood Banks and Life Sciences. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales and service offices in Europe and the United States. For more information, please visit www.inpeco.com.